SCHEMBL4897582

SCHEMBL4897582

CCN(c1coc(-c2ccc(C(C)(C)C)cc2)n1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
HCRTR2 O43614 1/20 0.38
HDAC3 O15379 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
RXRB P28702 1/20 0.36
TRPM8 Q7Z2W7 2/20 0.36
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
ESR1 P03372 2/20 0.35
KMT2A Q03164 1/20 0.35
AKR1C2 P52895 1/20 0.34
AKR1C1 Q04828 1/20 0.34
NSD2 O96028 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906508 0.92 LMNA (0.41) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4900715 0.91 ALDH1A1 (0.39) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4899823 0.91 LMNA (0.40) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4907412 0.90 HCRTR2 (0.36) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4895934 0.88 LMNA (0.40) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4906002 0.84 ALDH1A1 (0.39) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4904506 0.83 LMNA (0.40) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4895921 0.83 LMNA (0.40) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4895724 0.83 PPARG (0.38) ALDH1A1HCRTR2HDAC3HDAC11HDAC8
SCHEMBL4906847 0.83 ALDH1A1 (0.38) LMNAALDH1A1HCRTR2HDAC3HDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD LMNA 317/4885ALDH1A1 2664/4885HPGD 696/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885HPGD 724/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885HPGD 724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.